3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Recurrence
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Leukemia, Myeloid, Acute
1
Interventions
Cyclophosphamide
3
sodium-iodide symporter
1
ruxolitinib
1
fludarabine phosphate
1
fludarabine
1
cemiplimab
1
X-Rays
1
Whole-Body Irradiation
1
Vorinostat
1
Tacrolimus
1
Specimen Handling
1
Sirolimus
1
Photons
1
Peripheral Blood Stem Cell Transplantation
1
Particle Accelerators
1
Nivolumab
1
Mycophenolic Acid
1
Methotrexate
1
Melphalan
1
Magnetic Resonance Spectroscopy
1
Ipilimumab
1
Immunoglobulin G
1
Etoposide
1
Disulfides
1
Cyclosporine
1
CTLA-4 Antigen
1
Busulfan
1
Biopsy
1
A-dmDT390-bisFv(UCHT1) protein
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, T-Cell, Cutaneous
×
navitoclax
×
30 days
×
Clear all
No trials found.